You are here

P&T® Journal contents for July 2003


Advances in medicine have resulted in some unintended consequences that will require vim and vigor to address.
Sonja Sherritze
Physician Perspective
Thomas Marzili, MD
Cover Story
The author reviews the need to protect health care workers and first responders against potential smallpox outbreaks in the community
Timothy J. Babinchak, MD
Dr. Vogenberg discusses trends in pharmaceutical costs and the challenges involved in making medications accessible.
F. Randy Vogenberg, RPh, PhD
Many patients continue taking nonsteroidal anti-inflammatory drugs despite GI side effects and tend not to consult their physicians.
Christopher V. Chambers, MD, Walter L. Straus, MD, MPH, James J. Diamond, PhD, Lori A. Trapani, BS, BSN, RN, Mary Weeks, MS, and Nicole Somvanshi, MD
P&T Snapshot
Anne Mahoney, BA, and Ronald E. Polk, PharmD


Editor-in-Chief David Nash, MD, MBA, discusses the paradox of low-molecular-weight heparins in hospitalized patients with deep vein thrombosis.
David B. Nash, MD, MBA
Medication Errors
Matthew Grissinger discusses the confusion that sometimes occurs with supplements that contain phosphorus.
Matthew Grissinger, RPh
Prescription Washington
Stephen Barlas describes the proposed Medicare drug benefit bill and the convolutions involved in its passage.
Stephen Barlas
Drug News
P&T presents the latest information about approvals, indication changes, industry updates, and news from the FDA.
Drug Forecast
The authors review atomoxetine (Strattera®) for the treatment of ADHD.
Robert Carter, PharmD, Marlon Honeywell, PharmD, Tawana Carter, PharmD, Evans Branch III, PharmD, Bishop Hollifield, PharmD, and Michael Thompson, BCNSP, PharmD